Hydroxyurea remains effective over the long term among children with sickle cell disease, real-world data suggested. The average time on hydroxyurea was 5 years, with many children on the therapy for ...

(SAN DIEGO, December 11, 2011) – Research assessing the safety and efficacy of hydroxyurea therapy in pediatric patients with sickle cell disease (SCD) and the use of pre-operative transfusions for ...

Please provide your email address to receive an email when new articles are posted on . Three-quarters of women who became pregnant during hydroxyurea therapy had live births. Researchers observed no ...

Please provide your email address to receive an email when new articles are posted on . Researchers reported a mean annual days’ supply of hydroxyurea of 47.2 days per child in Michigan and 97.4 days ...

Hydroxyurea is generally contraindicated in patients with sickle cell disease who become or plan to become pregnant, but post-marketing safety data suggest that treatment continuation is safe. The ...

The risk of second malignancy was similar among patients aged 66 and older who were treated with and without hydroxyurea. The use of hydroxyurea to treat patients with myeloproliferative neoplasms ...

Neil B. Minkoff, MD: And how does hydroxyurea in general compare to l-glutamine? Ahmar U. Zaidi, MD: L-glutamine is a new player in the realm of sickle cell disease, and it’s also a preventive ...

(ORLANDO, Dec. 6, 2025) Taking the sickle cell drug hydroxyurea during or shortly before pregnancy does not appear to cause specific issues in newborns, according to the first prospective study of ...

Fewer ED visits per year and fewer hospital days per year seen in association with hydroxyurea use. HealthDay News — For children with sickle cell anemia (SCA), hydroxyurea has sustained clinical ...

Hydrea (hydroxyurea) is a prescription drug that’s used to help treat certain kinds of cancer. Hydrea can cause side effects that range from mild to serious. An example includes digestive problems ...